ŠKODA, Jan, Jakub NERADIL, Iva STANICZKOVÁ ZAMBO, Alena ŇUŇUKOVÁ, Peter MACSEK, Karolína BOŘÁNKOVÁ, Viera DOBROTKOVÁ, Pavel NĚMEC, Jaroslav ŠTĚRBA and Renata VESELSKÁ. Serial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma Cells. Cancers. BASEL: MDPI, 2020, vol. 12, No 1, p. 1-24. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers12010196.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Serial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma Cells
Authors ŠKODA, Jan (203 Czech Republic, belonging to the institution), Jakub NERADIL (203 Czech Republic, guarantor, belonging to the institution), Iva STANICZKOVÁ ZAMBO (203 Czech Republic, belonging to the institution), Alena ŇUŇUKOVÁ (703 Slovakia, belonging to the institution), Peter MACSEK (703 Slovakia, belonging to the institution), Karolína BOŘÁNKOVÁ (203 Czech Republic, belonging to the institution), Viera DOBROTKOVÁ (703 Slovakia, belonging to the institution), Pavel NĚMEC (203 Czech Republic, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic, belonging to the institution) and Renata VESELSKÁ (203 Czech Republic, belonging to the institution).
Edition Cancers, BASEL, MDPI, 2020, 2072-6694.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.639
RIV identification code RIV/00216224:14310/20:00116903
Organization unit Faculty of Science
Doi http://dx.doi.org/10.3390/cancers12010196
UT WoS 000516826700196
Keywords in English rhabdomyosarcoma; cancer stem cells; stemness; stem-like state; serial xenotransplantation; in vivo tumorigenicity assay; epithelial; mesenchymal phenotype
Tags 14110112, 14110321, podil
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 4/3/2021 10:50.
Abstract
Serial xenotransplantation of sorted cancer cells in immunodeficient mice remains the most complex test of cancer stem cell (CSC) phenotype. However, we have demonstrated in various sarcomas that putative CSC surface markers fail to identify CSCs, thereby impeding the isolation of CSCs for subsequent analyses. Here, we utilized serial xenotransplantation of unsorted rhabdomyosarcoma cells in NOD/SCID gamma (NSG) mice as a proof-of-principle platform to investigate the molecular signature of CSCs. Indeed, serial xenotransplantation steadily enriched for rhabdomyosarcoma stem-like cells characterized by enhanced aldehyde dehydrogenase activity and increased colony and sphere formation capacity in vitro. Although the expression of core pluripotency factors (SOX2, OCT4, NANOG) and common CSC markers (CD133, ABCG2, nestin) was maintained over the passages in mice, gene expression profiling revealed gradual changes in several stemness regulators and genes linked with undifferentiated myogenic precursors, e.g., SOX4, PAX3, MIR145, and CDH15. Moreover, we identified the induction of a hybrid epithelial/mesenchymal gene expression signature that was associated with the increase in CSC number. In total, 60 genes related to epithelial or mesenchymal traits were significantly altered upon serial xenotransplantation. In silico survival analysis based on the identified potential stemness-associated genes demonstrated that serial xenotransplantation of unsorted rhabdomyosarcoma cells in NSG mice might be a useful tool for the unbiased enrichment of CSCs and the identification of novel CSC-specific targets. Using this approach, we provide evidence for a recently proposed link between the hybrid epithelial/mesenchymal phenotype and cancer stemness.
Links
MUNI/A/1409/2019, interní kód MUName: Personalizovaná léčba v dětské onkologii: na cestě k "liquid dynamic medicine" a "N-of-1 clinical trials"
Investor: Masaryk University, Category A
NT13443, research and development projectName: Identifikace a charakterizace nádorových kmenových buněk u sarkomů dětského věku.
PrintDisplayed: 27/4/2024 02:34